Yoon Saunjoo L, Grundmann Oliver, Koepp Laura, Farrell Lana
College of Nursing, Department of Adult and Elderly, University of Florida, Gainesville, FL 32610, USA.
Altern Med Rev. 2011 Jun;16(2):134-51.
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder with a range of symptoms that significantly affect quality of life for patients. The difficulty of differential diagnosis and its treatment may significantly delay initiation of optimal therapy. Hence, persons with IBS often self-treat symptoms with non-prescribed pharmacological regimens and/or complementary and alternative medicines (CAM) and by modifying diet and daily activities. In addition, most common pharmacological approaches target IBS symptom management rather than treatment, and prescribed medications often result in significant side effects. The purposes of this review article are to: (1) address current issues related to IBS, including symptom presentation, diagnosis, and current treatment options; (2) summarize benefits and side effects of currently available pharmacological regimens and other symptom management strategies, with an emphasis on commonly used CAM therapies and diet modification; and (3) outline recommendations and future directions of IBS management based on systematic reviews, meta-analyses, and research findings.
肠易激综合征(IBS)是一种慢性胃肠道疾病,其一系列症状会显著影响患者的生活质量。鉴别诊断的困难及其治疗可能会显著延迟最佳治疗的开始。因此,肠易激综合征患者常常自行使用非处方药物治疗方案和/或补充与替代医学(CAM),并通过改变饮食和日常活动来缓解症状。此外,最常见的药物治疗方法针对的是肠易激综合征症状的管理而非治疗,并且处方药物常常会导致明显的副作用。这篇综述文章的目的在于:(1)探讨与肠易激综合征相关的当前问题,包括症状表现、诊断以及当前的治疗选择;(2)总结当前可用药物治疗方案和其他症状管理策略的益处与副作用,重点关注常用的补充与替代医学疗法以及饮食调整;(3)基于系统评价、荟萃分析和研究结果概述肠易激综合征管理的建议和未来方向。